BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Pre-Clinical Outsourcing

AiViva Biopharma Completes Enrollment in Phase 1 Trial of AIV007 for Wet AMD and DME

AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a Phase 1 tria...

August 26, 2024 | News

Nanoform and Takeda Collaborate on Pre-Clinical Development of Innovative Plasma-Derived Therapies

Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, announced that it is to enter into a pre-clinical development agreemen...

August 16, 2024 | News

Merck Acquires Mirus Bio for $600M to Strengthen Viral Vector Manufacturing Solutions

Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...

August 08, 2024 | News

Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...

August 07, 2024 | News

Rona Therapeutics Secures $35 Million Series A+ Financing to Advance siRNA Programs

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 M...

July 22, 2024 | News

Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091

Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...

July 17, 2024 | News

A*STAR and SingHealth Collaborate on SGD$18 Million TISHUMAP Project to Transform Drug Discovery in Asia

A*STAR’s Genome Institute of Singapore (GIS) has secured nearly SGD$18 million to develop an innovative data platform, TISHUMAP1. This platform is se...

July 09, 2024 | News

Immorna Biotherapeutics to Launch Phase 1/2 Study of Novel mRNA Therapeutic for Cancer

Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics a...

July 09, 2024 | News

HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...

May 29, 2024 | News

Nona Biosciences Signs License Agreement with AstraZeneca for Preclinical Antibodies in Oncology

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody disc...

May 23, 2024 | News

BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development

BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...

February 14, 2024 | News

Bruker acquires Spectral Instruments Imaging, enhancing its preclinical optical imaging capabilities

-Bruker Corporation (Nasdaq: BRKR) announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo opt...

February 07, 2024 | News

Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology

The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...

February 01, 2024 | News

WuXi Biologics Secures U.S. Patent for WuXiBody™ Antibody Tech

WuXiBodyTM has been widely adopted globally since its launch in 2018. It can effectively break through the CMC barriers for the development of many bi...

January 17, 2024 | News

Stay Connected